Human Insulin Market PPT: Opportunities by Types, Demand, Top Manufactures and Application in Grooming Regions - PowerPoint PPT Presentation

About This Presentation
Title:

Human Insulin Market PPT: Opportunities by Types, Demand, Top Manufactures and Application in Grooming Regions

Description:

Looking forward, the human insulin market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- – PowerPoint PPT presentation

Number of Views:54
Slides: 14
Provided by: IMARC
Category:

less

Transcript and Presenter's Notes

Title: Human Insulin Market PPT: Opportunities by Types, Demand, Top Manufactures and Application in Grooming Regions


1
Global Human Insulin Market Research and Forecast
Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Human Insulin Market Research
Report According to the latest report by IMARC
Group, titled "Human Insulin Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2021-2026," the global human
insulin market reached a strong growth in 2020.
Human insulin (HI) is a short-acting insulin
that is synthesized in laboratories. Commonly
utilized to mimic the function of natural insulin
present in humans, it is bio-engineered by
growing insulin proteins within E-coli bacteria
(Escherichia coli). It is available as a solution
and suspension and is required to be injected
subcutaneously. It is widely employed for
controlling the blood sugar levels of patients
with type I and II diabetes. HI functions by
aiding the sugar produced by the human body to
move from the blood to other body tissues where
it is used for energy. It can additionally stop
the liver from producing more sugar. Apart from
this, HI also assists in inhibiting the hepatic
glucose production and improving the protein
synthesis of the body. Request Free Sample
Report https//www.imarcgroup.com/human-insulin-m
arket/requestsample
4
Report Description and Highlights
Report Description
Global Human Insulin Market Trends The market
is primarily driven by the growing incidences of
diabetes and obesity on the global level. This
can be attributed to the shifting dietary
patterns, sedentary lifestyles led by the masses
and the growing geriatric population. In addition
to this, the rising awareness regarding the
complications of prolonged diabetes, such as
cataracts, heart attack and kidney failure, is
expected to facilitate the uptake of HI by
diabetic patients. Moreover, there has been a
gradual shift from standard needles for
administering HI to advanced alternatives. The
adverse effects of using a traditional needle
include infections and bloodborne pathogen
transmission. This has compelled healthcare
professionals to prescribe pen devices and safety
pen needles to administer HI as they cause
minimal discomfort. The market is further driven
by the increasing preference for biosimilar drugs
due to their cost-effectiveness and enhanced
efficiency. Furthermore, extensive research and
development (RD) undertaken by key market
players has led to the introduction of oral
insulin variants. These alternatives are
anticipated to offer a safe, effective and
convenient method of delivering insulin therapy,
which, in turn, will create a positive outlook
for the market. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description
  • Market Summary
  • Breakup by Product Type
  • Drugs
  • Human Insulin Analogs and Biosimilars
  • Rapid Acting
  • Long Acting
  • Premixed
  • Human Insulin Biologics
  • Short Acting
  • Intermediate Acting
  • Premixed
  • Delivery Devices
  • Pens
  • Reusable Pens
  • Disposable Pens
  • Pen Needles
  • Standard Pen Needles
  • Safety Pen Needles
  • Syringes


6
Report Description and Highlights
Report Description
  • Breakup by Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Retail Stores
  • Others
  • Breakup by Disease Type
  • Type I Diabetes
  • Type II Diabetes
  • Breakup by Region
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea

7
Report Description and Highlights
Report Description
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
  • Peru
  • Others
  • Middle East and Africa Turkey

8
Report Description and Highlights
Report Description
  • Iran
  • United Arab Emirates
  • Others
  • Note We are updating our reports, If you want
    latest primary and secondary data (2021-2026)
    with Cost Module, Business Strategy, Distribution
    Channel, etc. Click request free sample report.
  • Competitive Landscape with Key Players
  • B. Braun Melsungen AG
  • Becton Dickinson Company
  • Biocon
  • Eli Lilly and Company
  • Julphar
  • Novo Nordisk
  • Pfizer
  • Sanofi
  • Sedico
  • Wockhardt
  • Ypsomed Holding

9
Report Description and Highlights
Report Description

View Full Report with TOC List of Figure
https//www.imarcgroup.com/human-insulin-market
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us
Write a Comment
User Comments (0)
About PowerShow.com